Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers

Yunkai Yang; Changfeng Zhao; Zhida Wang; Feng Liu; Ming Zhao; Huiwen Yang; Jun Chen; Xuejing Chen; Min Shi; Dixing Jiang; Xiaoting Luo; Yue Duan; Yuchen Bai

doi:doi:10.18632/aging.205452

← Back

Research Paper Volume 16, Issue 2 pp 1696—1711

Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers

Figure 3. Calibration curve and ROC curve. Discrimination of the nomogram was evaluated by the ROC curve, AUC = 0.796 in the Ra cohort (A), AUC = 0.806 in the Ha cohort (B); calibration curves illuminate the agreement between the predicted risks of TFE3-RCC (C) and the observed incidence of TFE3-RCC (D). The dotted line represents the ideal flawless model.